drugset / Trial / NCT07332143
Psilocybin-Assisted Therapy
Phase 2
Not yet recruiting
150 enrolled
Emory University
Georgia Department of Veterans Services · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This pilot study will examine the safety, tolerability, acceptability, and efficacy of combination psilocybin + psychotherapy to decrease PTSD symptoms. Participants will be randomized into two different treatment groups, allowing the investigators to directly compare PE augmented with psilocybin and psilocybin-assisted psychotherapy.
Timeline
- Start
- 2026-06
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |